Intravenous immunoglobulin for mortality and inflammatory status in patients with sepsis: a retrospective database study
BackgroundSepsis is a life-threatening condition caused by severe infection. The efficacy of intravenous immunoglobulin (IVIG) as adjunctive therapy on mortality remains controversial. Moreover, IVIG may favorably affect sepsis-induced immunosuppression like persistent inflammation, immunosuppressio...
Saved in:
Main Authors: | Hayabusa Takano, Naoki Kanda, Yuji Wakimoto, Hiroyuki Ohbe, Kensuke Nakamura |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1511481/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prophylactic intravenous immunoglobulin use in allogeneic stem cell transplantation; does intravenous immunoglobulin affect survival, sepsis, and engraftment time?
by: Ahmet Kaya, et al.
Published: (2024-12-01) -
Intravenous immunoglobulin in the management of idiopathic inflammatory myositis: A single centre retrospective review
by: Jeet Hemantkumar Patel, et al.
Published: (2020-01-01) -
The New Formulations of Immunoglobulin Replacement Therapies and Future Aspects
by: Elif Karakoç-aydıner
Published: (2024-04-01) -
Plasma exchange alone versus combination with intravenous immunoglobulin/methylprednisolone pulse therapy in severe systemic rheumatic diseases: a retrospective study
by: Jing Guo, et al.
Published: (2024-12-01) -
Predictive modeling of consecutive intravenous immunoglobulin treatment resistance in Kawasaki disease: A nationwide study
by: Eun Jung Cheon, et al.
Published: (2025-01-01)